Which proton‑pump inhibitor (PPI) is recommended?

Recommended Proton Pump Inhibitor

For most clinical indications, omeprazole 20-40 mg is the recommended PPI, with esomeprazole or rabeprazole as preferred alternatives when cost is equivalent or when specific pharmacokinetic advantages are needed.

Primary Recommendation by Clinical Context

For Eosinophilic Esophagitis (EoE)

• Omeprazole is the only PPI that has been specifically assessed for EoE treatment 1
• Dose: Omeprazole 20 mg twice daily for at least 8-12 weeks before assessing histological response 1
• This dosing achieved response rates of 50.8% compared to 35.8% with standard or low-dose regimens 1
• In pediatric patients, omeprazole 1 mg/kg twice daily (maximum 40 mg twice daily) demonstrated 70.1% long-term histological remission over 12 months 1

For Helicobacter pylori Eradication

• Minimum dose: 40 mg omeprazole or equivalent twice daily 2
• If cost is equivalent, use 40 mg rabeprazole or esomeprazole twice daily 2
• Relative potency equivalents 2:
  • 40 mg pantoprazole = 9 mg omeprazole (avoid pantoprazole)
  • 30 mg lansoprazole = 27 mg omeprazole
  • 20 mg esomeprazole = 32 mg omeprazole
  • 20 mg rabeprazole = 36 mg omeprazole
• Rabeprazole maintains efficacy despite declining eradication rates with standard triple therapy, while omeprazole and lansoprazole show significant declines 3
• Recent data show esomeprazole-based quadruple regimens achieved 75.2% eradication versus 65.8% with ilaprazole, 65.4% with omeprazole, and 70.9% with rabeprazole 4

For GERD and Peptic Ulcer Disease

• Any PPI may be used as absolute differences in efficacy for symptom control and tissue healing are small 5
• Standard dosing: once daily 30-60 minutes before a meal 5
• For inadequate response: escalate to twice-daily dosing before considering treatment failure 6
• Omeprazole 20-40 mg twice daily is the standard recommendation 7

For Upper GI Bleeding (Portal Hypertensive and Non-Variceal)

• PPIs are strongly recommended for both portal hypertensive bleeding 8 and non-variceal bleeding 9
• High-dose regimen: 80 mg bolus followed by 8 mg/hour infusion for 72 hours after endoscopic therapy 9
• Pre-endoscopy empirical therapy with high-dose PPI should be considered 9

For Gastroprotection with Antithrombotic Therapy

• PPIs are recommended in patients at increased risk of GI bleeding (elderly, history of GI bleeding/peptic disease, high alcohol consumption, chronic NSAID/steroid use, combination antithrombotic therapy) 10
• Avoid omeprazole and esomeprazole when used with clopidogrel due to CYP2C19 inhibition reducing clopidogrel's active metabolite 10
• While drug-drug interaction concerns exist, no univocal effects on ischemic events or stent thrombosis have been demonstrated 10

Key Pharmacological Distinctions

Advantages of Newer PPIs (Rabeprazole and Esomeprazole)

• More rapid and profound acid inhibition compared to older agents 11, 12
• Rabeprazole has balanced hepatic metabolism (both CYP-mediated and non-enzymatic), making it less affected by CYP2C19 genetic polymorphisms 11, 12
• Rabeprazole and pantoprazole have the lowest risk for drug-drug interactions 13, 12
• Omeprazole has the highest risk for clinically significant pharmacokinetic drug interactions 12

Metabolism and Genetic Considerations

• CYP2C19 polymorphisms substantially increase plasma levels of omeprazole, lansoprazole, and pantoprazole, but not rabeprazole 12
• This genetic variability can affect inter-patient response and clinical efficacy 11, 12

Common Pitfalls to Avoid

1. Do not use pantoprazole for H. pylori eradication - it has significantly lower acid suppression potency (40 mg pantoprazole = only 9 mg omeprazole) 2

2. Do not reduce PPI dose in EoE management - especially in primary care, as lower doses show significantly reduced efficacy 1

3. Avoid omeprazole/esomeprazole with clopidogrel when alternative PPIs are available, though absolute risk remains uncertain 10

4. Do not prescribe twice-daily dosing without clear indication - most patients with uncomplicated GERD should start with once-daily therapy 6

5. Ensure proper timing - PPIs should be taken 30-60 minutes before meals for optimal efficacy 5, 14